Table 1.
Characteristics of Patients With and Without PARDS
| Characteristics | No PARDS n = 117 |
PARDS n = 233 |
P |
|---|---|---|---|
| No. (%) | |||
| Female | 55 (47) | 106 (45) | .79 |
| Non-Hispanic white | 62 (53) | 127 (55) | .73 |
| RESTORE intervention site | 75 (64) | 143 (62) | .65 |
| Primary diagnoses | |||
| Pneumonia | 35 (30) | 89 (38) | .13 |
| Bronchiolitis | 19 (16) | 41 (18) | .75 |
| Acute respiratory failure related to sepsis | 21 (18) | 51 (22) | .39 |
| Asthma or reactive airway disease | 20 (17) | 22 (9) | .04 |
| Aspiration pneumonia | 10 (9) | 15 (6) | .47 |
| Other | 12 (10) | 15 (6) | .21 |
| Medical history of | |||
| Prematurity | 10 (9) | 29 (12) | .27 |
| Asthma | 28 (24) | 36 (15) | .05 |
| Seizure disorder | 11 (9) | 21 (9) | .91 |
| Cancer | 9 (8) | 16 (7) | .78 |
| Neurologic/neuromuscular disorder | 12 (10) | 17 (7) | .34 |
| Chromosomal abnormality | 7 (6) | 23 (10) | .22 |
| Immunodeficiency | 3 (3) | 7 (3) | 1.0 |
| Deaths | 13 (11) | 14 (6) | .09 |
| PRISM III, median (IQR) | 7 (3-13) | 9 (5-14) | .08 |
| Age, median (IQR), y | 4.7 (0.8-11.1) | 4.6 (0.9-12.2) | .41 |
IQR = interquartile range; PARDS = pediatric ARDS; PRISM III = pediatric risk of mortality III.